Stock Target: Healthcare Services Stock with 38% Upside Recommended by ICICI Securities
ICICI Securities and Motilal Oswal reiterated ‘Buy’ ratings on Sagility India Ltd after the company reported a stronger-than-estimated Q1FY27, with resilient margins despite wage cost pressure. ICICI raised its target to ₹54 (about 31% upside), citing 15.2% YoY revenue growth and 23.8% EBITDA margin. Motilal set ₹57 (about 38% upside) after INR revenue, EBITDA and PAT beats, and expects FY27 normalization.
How this was made
The 30-second read
Why it matters
The actionable element is the combination of a reported Q1FY27 beat (revenue and EBITDA margin resilience) plus brokerages revising price targets upward while reiterating Buy, framing FY27 as normalization with potential margin upside if wage impact is lower.
Market read
Traders can use the PT revisions and the specific operating drivers (revenue beat, EBITDA margin resilience, client additions, wage impact, AI headwind) to reassess near-term expectations for FY27 execution.
What to watch
Client concentration easing is positive, but the top-10 still remains high (84.1%), so any churn or slower cross-selling from CareSeed could pressure the FY27 revenue-to-margin conversion.
Background
The company is a healthcare-focused BPM player that completed the CareSeed acquisition and is guiding FY27 low double-digit organic constant-currency revenue growth with adjusted EBITDA margin of 24-25%.
Market effects
Supports sentiment for healthcare BPM/analytics services that can defend margins through wage inflation and monetize payer/provider cross-sell.
Highlights India wage-cost sensitivity (Karnataka and Telangana minimum wage revisions) as a key margin driver for service exporters.
Limited direct global read-across, but acquisition of a US-based analytics firm may reinforce cross-border delivery and Medicare Advantage analytics demand.
Counterpoint
The article flags potential 2-3% FY27 headwind from AI cannibalization, and FY27 is described as a normalization year, which could cap upside if growth decelerates faster than expected.
Key entities
- companySagility India Limited
Healthcare BPM provider; Q1FY27 beat, resilient margins, and CareSeed acquisition driving client growth; brokerages raised targets.
- brokerageICICI Securities
Maintained Buy, revised target to ₹54 from ₹51, citing revenue growth beat and resilient EBITDA margin despite wage pressure.
- brokerageMotilal Oswal
Maintained Buy, set target at ₹57, citing INR revenue and profit beats and FY27 normalization thesis.
- acquisition targetCareSeed
US-based healthcare analytics firm acquired during the quarter, adding 30 clients and strengthening Medicare Advantage capabilities.
